Hancom MDS Inc (086960) — Capital Reinvestment Ratio
Latest as of March 2026:
0.27x
Hancom MDS Inc (086960) has a Capital Reinvestment Ratio of 0.27x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩6.11 Billion) in capital expenditures (₩1.65 Billion). See Hancom MDS Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.27x
Capex / Operating Cash Flow
Operating Cash Flow
₩6.11 Billion
KRW
Capital Expenditures
₩1.65 Billion
KRW
Data as of
Mar 2026
Most recent filing
Hancom MDS Inc Capital Reinvestment Ratio (2007–2025)
This chart tracks Hancom MDS Inc's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Hancom MDS Inc (2007–2025)
Year-by-year Capital Reinvestment Ratio for Hancom MDS Inc from 2007 to 2025. For live market cap and broader valuation context, see Hancom MDS Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | ₩16.12 Billion | ₩4.04 Billion | ▼ -48.8% |
| 2024 | 0.49x | ₩2.90 Billion | ₩1.42 Billion | ▲ +1514.7% |
| 2023 | 0.03x | ₩26.32 Billion | ₩798.10 Million | ▼ -93.2% |
| 2021 | 0.45x | ₩2.83 Billion | ₩1.27 Billion | ▲ +22.0% |
| 2020 | 0.37x | ₩6.78 Billion | ₩2.48 Billion | ▼ -17.7% |
| 2019 | 0.44x | ₩4.95 Billion | ₩2.20 Billion | ▲ +146.7% |
| 2018 | 0.18x | ₩20.47 Billion | ₩3.69 Billion | ▼ -45.1% |
| 2017 | 0.33x | ₩3.57 Billion | ₩1.17 Billion | ▼ -54.3% |
| 2015 | 0.72x | ₩6.27 Billion | ₩4.50 Billion | ▲ +393.2% |
| 2014 | 0.15x | ₩12.73 Billion | ₩1.85 Billion | ▼ -45.1% |
| 2013 | 0.27x | ₩12.06 Billion | ₩3.20 Billion | ▼ -71.4% |
| 2012 | 0.93x | ₩6.63 Billion | ₩6.17 Billion | ▲ +563.2% |
| 2011 | 0.14x | ₩4.76 Billion | ₩667.39 Million | ▲ +4.5% |
| 2007 | 0.13x | ₩7.05 Billion | ₩946.15 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow